Clinical Trial Update: Efficacy and Safety of Neoadjuvant Sintilimab Plus FLOT Versus Sintilimab Plus SOX Phase II Clinical Trial for Patients With Locally Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating neoadjuvant sintilimab plus FLOT versus sintilimab plus SOX in locally advanced gastric cancer; the study is currently not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• DOCETAXEL (DOCETAXEL)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)
• Sintilimab (sintilimab)

Snippet

Sponsor: Xijing Hospital | Conditions: Neoadjuvant Chemotherapy, Sintilimab | Phase 2 | Status: NOT_YET_RECRUITING